🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
The primary objective of the study is to compare sacituzumab tirumotecan co...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix ( Site 0147)
Start Date
2023-12-15
Trial ID
NCT06170788
Treatments Being Tested
Immunotherapeutic approaches recently have demonstrated clinical efficacy i...
Status
Recruiting
Location
Aix-en-Provence - CH
Start Date
2022-05-02
Trial ID
NCT05255302
Treatments Being Tested
The goal of this clinical trial is to learn if the timing of treatments pla...
Status
Not Yet Recruiting
Location
BC Cancer - Abbotsford
Start Date
2026-05
Trial ID
NCT07346053
Treatments Being Tested
Study to evaluate the efficacy of treatment by radiotherapy and pembrolizum...
Status
Recruiting
Location
Institut Sainte Catherine
Start Date
2021-12-01
Trial ID
NCT04747054
Treatments Being Tested
TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion cl...
Status
Recruiting
Location
Arizona Oncology Associates
Start Date
2020-07-14
Trial ID
NCT04485013
This phase III trial compares whether the addition of pembrolizumab to radi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-04-09
Trial ID
NCT04214067
Although immune checkpoint inhibitors (ICIs) have substantially extended su...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09
Trial ID
NCT07597070
Treatments Being Tested
This is a multicenter, open-label, randomized controlled clinical trial des...
Status
Completed
Location
Hallym University Medical Center
Start Date
2024-02-08
Trial ID
NCT06249854
Treatments Being Tested
Vorasidenib in combination with pembrolizumab in participants with recurren...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2023-01-20
Trial ID
NCT05484622
Treatments Being Tested